Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects. [electronic resource]
Producer: 20161005Description: 47-55 p. digitalISSN:- 1552-4604
- Adolescent
- Adult
- Anticholesteremic Agents -- adverse effects
- Atorvastatin -- adverse effects
- Benzimidazoles -- adverse effects
- Contraceptives, Oral, Combined -- adverse effects
- Cytochrome P-450 CYP3A Inhibitors -- adverse effects
- Drug Combinations
- Drug Interactions
- Ethinyl Estradiol -- adverse effects
- Female
- Healthy Volunteers
- Humans
- Male
- Middle Aged
- Norgestrel -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.